Press Release – New York, NY – March 6, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented AYTU Bioscience, Inc. (NASDAQ: AYTU) in a $12 million public offering of Class A Units, comprising common stock and warrants and Class B Units comprising Series B Preferred Stock and Warrants. A total of 19,520,000 Class A Units were sold at a price of $0.45 per unit and 3,216 Class B Units were sold at a price of $1,000 per unit. The warrants are exercisable at a price of $0.54 per share for a term of 5 years. Joseph Gunnar & Co. acted as the Sole Book Running Managing Underwriter and Fordham Financial Management, Inc. acted as the Lead Managing Underwriter.
AYTU is a specialty Life Sciences Company focused on global commercialization of novel products in the field of urology. The Sichenzia Ross Ference Kesner LLP team was led by Partners, Gregory Sichenzia and Marcelle Balcombe and Counsel, Jeff Cahlon.
Visit SRFC's LinkedIn page
- Sichenzia Ross Ference Carmel LLP Represents ThinkEquity in $2.5 Million Public Offering of CEL-SCI Corporation - March 19, 2025
- Sichenzia Ross Ference Carmel Names Evan Cappelli as its Corporate and Securities Department Managing Partner - March 18, 2025
- Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in $15 Million Private Placement Offering of Plus Therapeutics - March 4, 2025
